MannKind Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
MannKind Corporation MNKD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.01 12:19:05
Close Price Low Price High Price Open Price Previous Close
1.97 2.04 2.02 2.01
Bid Price Ask Price Spread News
2.00 2.01 0.01 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,736 1,143,763 $ 2.00 $ 2,290,670 2,112,519 0.80 - 2.48
Last Trade Time Type Quantity Stock Price Currency
12:19:05 100 $ 2.01 USD

MannKind Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 460.64M 229.17M 227.03M $ 63.04M $ -44.90M -0.27 -10.26
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

MannKind News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNKD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.002.091.871.992,302,3370.010.5%
1 Month1.962.091.781.901,851,2540.052.55%
3 Months1.622.151.521.812,229,4860.3924.07%
6 Months1.212.481.141.722,788,8080.8066.12%
1 Year1.302.480.801.532,662,2520.7154.62%
3 Years4.214.250.801.862,887,278-2.20-52.26%
5 Years3.366.960.411.823,711,839-1.35-40.18%

MannKind Description

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.